Article
Apolipoprotein E and complement C3 polymorphism and their role in the response to gemfibrozil and low fat low cholesterol therapy.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies - 1 Nov 1995
Nemeth A, Szakmary K, Kramer J, Dinya E, Pados G, Fust G, Huettinger M
Abstract excerpt
Three different allelic variants of apolipoprotein E determine, in concert with other gene products, the levels of plasma lipoproteins. Recently, cleavage products of the complement C3 molecule have also been implicated in determining plasma triacylglycerol concentrations. This study presents dat...
Topics
- Adult
- Aged
- Alleles
- Apolipoproteins
- Apolipoproteins E
- Cholesterol
- Cholesterol, Dietary
- Cholesterol, HDL
- Combined Modality Therapy
- Complement C3
- Diet, Fat-Restricted
- Female
- Gemfibrozil
- Genetic Variation
- Humans
